{"id":"W2019150265","doi":"10.1053/j.gastro.2014.08.003","title":"Converging Goals of Treatment of Inflammatory Bowel Disease From Clinical Trials and Practice","year":2014,"lang":"en","type":"review","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":216,"is_retracted":false,"has_abstract":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Janssen Pharmaceuticals; Janssen Biotech; Janssen Research and Development; Genentech; Novo Nordisk; Optimer Pharmaceuticals; Luitpold Pharmaceuticals; Shire; Bristol-Myers Squibb; Orexigen Therapeutics; Amgen; Boehringer Ingelheim; G1 Therapeutics; Celgene; Pfizer; MedImmune; GlaxoSmithKline; AbbVie; Abbott Laboratories","keywords":"Medicine; Clinical trial; Inflammatory bowel disease; Clinical Practice; Disease; Ulcerative colitis; Endoscopy; Crohn's disease; Intensive care medicine; Physical therapy; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006071807,0.001199729,0.003887831,0.002389268,0.0006055558,0.003438918,0.002080248,0.003204521,0.003959644],"category_scores_gemma":[0.006220827,0.0004629909,0.001190754,0.001958228,0.0024477,0.004115869,0.002400917,0.007654562,0.00167452],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001849521,"about_ca_system_score_gemma":0.003886844,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001228171,"about_ca_topic_score_gemma":0.002394485,"domain_scores_codex":[0.9984692,0.0005199583,0.0002301481,0.0001833547,0.0004745985,0.0001227665],"domain_scores_gemma":[0.9956981,0.002772767,0.0003208783,0.0001119171,0.0007743496,0.0003219963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004271272,0.0001461768,0.0003518341,0.01683716,0.00020139,0.0002719324,0.0001288109,0.000795982,0.0009477962,0.02504936,0.04976038,0.9050821],"study_design_scores_gemma":[0.0001803895,0.0002868928,0.0007309189,0.0151926,0.0002592421,0.0007324292,0.0002246373,0.0002796126,0.0002965292,0.02728713,0.9544711,0.00005849662],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007993597,0.9937233,0.0004001925,0.004445632,0.0005340413,0.000007966751,0.00001732599,0.00001184999,0.0007797963],"genre_scores_gemma":[0.001124574,0.9928643,0.0008662586,0.003562077,0.001178334,0.00001749467,0.00003380209,0.000005752307,0.0003474853],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006071807,"threshold_uncertainty_score":0.03211117,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06271457374047619,"score_gpt":0.402497071479209,"score_spread":0.3397824977387329,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}